Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D01SPJ
|
||||
| Former ID |
DIB009765
|
||||
| Drug Name |
Litenimod
|
||||
| Synonyms |
Li-28; CpG oligonucleotide immunomodulator (cancer), Oligovax
|
||||
| Indication | Glioblastoma multiforme [ICD9: 191; ICD10:C71] | Phase 1 | [551464] | ||
| Company |
Oligovax SAS
|
||||
| Formula |
C256H322N95O129P25S25
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Toll-like receptor 9 | Target Info | Modulator | [543477] | |
| NetPath Pathway | BCR Signaling Pathway | ||||
| PANTHER Pathway | Toll receptor signaling pathway | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.